Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-12-20FDA Approved: PREVYMIS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplementary application for PREVYMIS (letermovir) from Merck Sharp & Dohme LLC, updating the labeling.
-
FDA approval · 2019-12-20FDA Approved: PREVYMIS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for PREVYMIS (letermovir) from Merck Sharp & Dohme LLC.
-
FDA approval · 2019-08-29FDA Approved: PREVYMIS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Prevymis (letermovir) from Merck, expanding its approved use.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") [Phase 4]
Phase 4 clinical trial update on CMV antiviral prevention strategies in cytomegalovirus infection; results posted after completion.
-
FDA approval · 2019-03-05FDA Approved: PREVYMIS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for PREVYMIS (letermovir) submitted by Merck Sharp & Dohme LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant [Phase 4]
Phase 4 trial in de novo kidney transplant recipients comparing Everolimus with very low tacrolimus to enteric-coated mycophenolate sodium w…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: A Study in Adolescent Females to Explore Cytomegalovirus Infection [NA]
A completed clinical trial in adolescent females evaluating cytomegalovirus infection; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Study of SHP620 (Maribavir) in Healthy Adults [Phase 1]
Phase 1 trial update of SHP620 (Maribavir) in healthy adults has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) [Phase 3]
A Phase 3 study evaluating ASP0113, a therapeutic vaccine, in CMV-seropositive recipients undergoing allogeneic hematopoietic cell transplan…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A [Phase 4]
A Phase 4 trial comparing an immunosuppressive regimen including everolimus with reduced cyclosporine versus mycophenolic acid with standard…
-
FDA approval · 2018-11-08FDA Approved: GANCICLOVIR — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the original application for a generic version of ganciclovir (ganciclovir sodium) from Slate Run Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating nilotinib for cytomegalovirus prophylaxis and treatment following allogeneic hematopoietic stem cell trans…
-
FDA approval · 2018-08-02FDA Approved: VALCYTE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for VALCYTE (valganciclovir hydrochloride) submitted by H2-Pharma, LLC.
-
FDA approval · 2018-08-02FDA Approved: VALCYTE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for VALCYTE (valganciclovir) submitted by H2-Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Clinical Performance Evaluation of DxN CMV Assay
Clinical trial update notes the terminated status of a study evaluating the performance of Beckman Coulter's DxN CMV Assay for cytomegalovir…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient [Phase 1]
Phase 1 trial evaluating the tolerability and safety of BD03 to prevent cytomegalovirus and BK virus reactivation in kidney transplant recip…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV [Phase 1]
Phase 1 trial assessing safety and immunogenicity of an HCMV vaccine by Hookipa Biotech has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis
Clinical trial update notes a study on cytomegalovirus infection in patients with steroid-refractory ulcerative colitis, with the current tr…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients [Phase 2]
Phase 2 trial update on CSJ148 in stem cell transplant patients assessing efficacy and safety for HCMV; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study [Phase 3]
Phase 3 clinical trial update for an immunoprophylactic adoptive cellular therapy targeting cytomegalovirus infection.
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Alternate Donor Study of Pre-Emptive Cellular Therapy [Phase 2]
Phase 2 clinical trial update for pre-emptive cellular therapy using alternate donors in cytomegalovirus infection.
-
FDA approval · 2017-12-12FDA Approved: VALGANCICLOVIR HYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Inc)
FDA approves valganciclovir hydrochloride as an original generic drug via ANDA 206876 from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2017-12-08FDA Approved: GANCICLOVIR — Original Application (Pharmascience Inc.)
FDA approved Pharmascience Inc.'s original ANDA for ganciclovir sodium, a generic version of ganciclovir. This approval makes a generic anti…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant [Phase 2]
A Phase 2 trial evaluating ganciclovir given by infusion and by mouth to treat cytomegalovirus infection in patients after donor bone marrow…
-
FDA approval · 2017-11-08FDA Approved: PREVYMIS — Original Application (Merck Sharp & Dohme LLC)
The FDA approved PREVYMIS (letermovir) in an original application for the prophylaxis of cytomegalovirus infection in CMV-seropositive adult…